Amoxicillin induced erythematous maculopapular rashes: a case report

Authors

  • Dhakchinamoorthi Krishna Kumar Department of Pharm D, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai, Tamil Nadu
  • Ravichandran Rajganesh Department of Pharm D, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai, Tamil Nadu
  • Dilli Batcha Jaya Shree Department of Pharm D, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai, Tamil Nadu
  • Sam Nikhil Cherian Department of Pharm D, C.L. Baid Metha College of Pharmacy, Thoraipakkam, Chennai, Tamil Nadu
  • Thayub Mohamed Department of Clinical Pharmacy, Frontier Life line Hospital, Chennai, Tamil Nadu

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20201763

Keywords:

Amoxicillin, Adverse drug reaction, Maculopapular erythematous rashes, Pharmacovigilance

Abstract

Cutaneous adverse reactions (CAR) can occur with any class of drugs, however more widely caused by various antibiotics. Amoxicillin is a broad-spectrum, bactericidal, beta-lactam antibiotic, widely used for combating various infections. Cutaneous drug eruptions are known to be reported common while using penicillin class of drugs, specifically among children. These immune-mediated bizarre drug eruptions were range from mild to severe drug-induced cutaneous reactions, such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). The present case reported with maculopapular, erythematous rashes induced by amoxicillin in a nine-year-old male patient. Amoxicillin was prescribed for his hyperactive respiratory disease and subsequently after three days developed generalized maculopapular erythematous rashes as a result of an antibiotic-induced skin rash. The present case is being reported to add more data, also to emphasize and gather the information for evidence-based practice and to promote efficient pharmacovigilance adverse drug reaction reporting.

References

Bush K. β‐lactam antibiotics: Penicillin and other β‐lactam antibiotics. In: Finch RG, Greenwood D, Norrby SR., and Whitley RJ. Antibiotic and chemotherapy: anti‐infective agents and their use in therapy. 8th edition. Philadelphia (USA): Churchill Livingstone, Elsevier Science Limited; 2003: 224‐278.

Matho A, Mulqueen M, Tanino M, Quidort A, Cheung J, Pollard J, et al. High-dose versus standard-dose amoxicillin/clavulanate for clinically-diagnosed acute bacterial sinusitis: A randomized clinical trial. PLoS ONE. 2018;13(5):0196734.

Sabino HA, Valera FC, Aragon DC. Amoxicillin-clavulanate for patients with acute exacerbation of chronic rhinosinusitis: a prospective, double-blinded, placebo-controlled trial. Int Forum Allergy Rhinol. 2017;7(2):135-42.

Chen LE, Shen YZ, Jiang DY, Feng GL, Zhang XL, Wang YF. Amoxicillin and clavulanate potassium in treating children with suppurative tonsillitis. J Biol Regul Homeost Agents. 2017;31(3):625-9.

Kurian J, Mathew J, Sowjanya K, Chaitanya KRK, Ramesh M, Sebastian J, et al. Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study. Indian J Pediatr. 2016;83(5):414-9.

Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: clinical pattern and causative agents - a 6 years series from Chandigarh, India. J Postgrad Med. 2001;47:95-9.

Sharma VK, Sethuraman G. Adverse cutaneous reactions to drugs: An overview. J Postgrad Med. 1996;42:15-22.

Naranjo CA, Busto U, Sellers EM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-45.

The use of the WHO-UMC system for standardized case causality assessment. Accessed from: https://www.who.int/medicines/areas/quality_safety/safety_efficacy/WHOcausality_assessment.pdf. Accessed on 28 February 2020.

Merchant SR, Taboada J. Systemic diseases with cutaneous manifestations. Vet Clin North Am Small Anim Pract. 1995;25(4):945-59.

Deng Q, Fang X, Zeng Q, Lu J, Jing C, Huang J. Severe cutaneous adverse drug reactions of Chinese inpatients: a meta-analysis. A Bras Dermatol. 2017;92(3):345-9.

Zhang H, Zhou YP, Peng HJ. Predictive symptoms and signs of severe dengue disease for patients with dengue fever: a meta-analysis. Biomed Res Int. 2014;2014:359308.

Renn CN, Straff W, Dorfmuller A, Masaoudi AT, Merk HF, Sachs B. Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity. Br J Dermatol. 2002;147(6):1166-70.

Sharma VK, Sethuraman G. Adverse cutaneous reactions to drugs: An overview. J Postgrad Med. 1996;42:15-22.

Brar BK, Kaur J, Kumar S, Sethi N, Kumar R. Cutaneous adverse drug reactions profile in a tertiary care hospital in North India. J Pakistan Association Dermatologists. 2017;27(2):158-63.

Hal TW, Sluiter HE, Scheur MR, Ginkel CJ. A case of acute generalised pustulosis due to amoxicillin/clavulanic acid. Neth J Med. 2014;72(4):245-6.

Villalba AA, Haq M, Zhang C, Thakkar J. Amoxicillin/ Clavulanic Acid-Induced Agranulocytosis: A Case Report and Review of the Literature. Case Reports in Hematology Report. 2019;5718716:1-4.

Chams S, Sayegh ES, Hamdon M, Kumar S, Tegeltija V. Amoxicillin/clavulanic acid-induced pancreatitis: case report. BMC Gastroenterol. 2018;18(1):122.

Shimi A, Touzani S, Derkaoui A, Khatouf M. Kounis syndrome associated with amoxicillin/clavulanic acid. Saudi J Anaesth. 2016;10:444-5.

Ralapanawa DM, Kularatne SA. Kounis syndrome secondary to amoxicillin/clavulanic acid administration: a case report and review of literature. BMC Res Notes. 2015;8:97.

Pharmacovigilance Programme of India (PvPI), Performance Report 2018-19. Available at: https://ipc.gov.in/images/ePvPI_Annual_Performance_Report_2018-19.pdf. Accessed on 28 February 2020.

Downloads

Published

2020-04-23

How to Cite

Krishna Kumar, D., Rajganesh, R., Jaya Shree, D. B., Cherian, S. N., & Mohamed, T. (2020). Amoxicillin induced erythematous maculopapular rashes: a case report. International Journal of Basic & Clinical Pharmacology, 9(5), 806–809. https://doi.org/10.18203/2319-2003.ijbcp20201763

Issue

Section

Case Reports